Khrom Dermatology & Aesthetics
2797 Ocean Pkwy.
Brooklyn, NY 11235 | Directions
Aesthetics: 855-507-7282
General Dermatology: 718-751-0674
Khrom Dermatology & Aesthetics
Staten Island

2076 Hylan Blvd. Suite 1
Staten Island, NY 10306 | Directions

FDA Approves Sarecycline for Moderate to Severe Acne

Medscape Derm

The US Food and Drug Administration (FDA) has approved sarecycline (Seysara, Almirall) for patients aged 9 years and older with inflammatory lesions associated with non-nodular moderate to severe acne vulgaris. Sarecycline is a new first-in-class tetracycline-derived oral antibiotic and the first one specifically designed for dermatologic use in 40 years, according to a company news release.

“We are proud to have obtained the FDA’s approval for Seysara, which will bring a new option for the many patients with unmet medical needs,” Peter Guenter, chief executive officer, Almirall, said in the news release.

Sarecycline is a once-daily oral tablet with anti-inflammatory properties that can be taken with or without food.

Read the article click here

Back to Hot off the Press Page

Real Patients. Real Results.

Google Review by J. Skylar
This was my second visit and i can say i love the service. Dr. Fiadorchanka is amazing! Any concerns I had, she resolved in such a professional and friendly manner. I really recommend her.
Close
Khrom Dermatology
Contact Us Form
Date of Birth *
By submitting the above form you agree and accept our Privacy Policy
I Agree
Book an Appointment